Sign Up to like & get
recommendations!
1
Published in 2022 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359221133893
Abstract: Background: SARS-CoV-2 (COVID-19) elicits a T-cell antigen-mediated immune response of variable efficacy. To understand this variability, we explored transcriptomic expression of angiotensin-converting enzyme 2 (ACE2, the SARS-CoV-2 receptor) and of immunoregulatory genes in normal lung…
read more here.
Keywords:
normal lung;
high ace2;
expression;
lung ... See more keywords